UNC researchers kill drug-resistant lung cancer with 50 times less chemo

Posted Jan 18, 2016
The cancer drug paclitaxel just got more effective. For the first time, researchers from the University of North Carolina at Chapel Hill have packaged it in containers derived from a patient’s own immune system, protecting the drug from being destroyed by the body’s own defenses and bringing the entire payload to the tumor. (UNC.edu)

Related: Campus Connections

Late night on Franklin Street: A guide to finding your next midnight snack
A landmark of Chapel Hill and Franklin Street, Time-Out has been serving comfort Southern food since 1978 and still is all day, every day. According...
Sat Apr 27, 2024

UNC Hospitals Named One of World’s Best Hospitals in 2024
UNC Hospitals in Chapel Hill earned a spot on Newsweek’s “World’s Best Hospitals 2024” list. It’s one of three UNC Health institutions named to the...
Fri Apr 26, 2024

UNC Disc Golf Team Wins National Championship
Carolina Disc Golf is a club team dedicated to growing the game of disc golf. UNC traveled to Rock Hill, South Carolina last weekend to...
Wed Apr 24, 2024

Multiple UNC Graduate School Programs Ranked in Nation’s Top 10
Several University of North Carolina graduate programs were ranked in the top 10 of their respective categories by the U.S. News & World Report this...
Sun Apr 21, 2024